DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ocinaplon
Ocinaplon
BMC Pharmacology Biomed Central
GABA Receptors
Zebrafish Behavioural Profiling Identifies GABA and Serotonin
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Positive Allosteric Modulators of the Strychnine Sensitive Glycine Receptor
Comparative Cue Generalisation Profiles of L-838,417, SL651498
Portrait of DNA Methylated Genes Predictive of Poor Prognosis in Head
Stembook 2018.Pdf
GABAA Receptor a Subunits Differentially Contribute to Diazepam Tolerance After Chronic Treatment
Customs Tariff - Schedule
An Overview of the Synthetic Routes to the Best Selling Drugs Containing 6-Membered Heterocycles
GABAA Receptor Subtype- and Function-Selective Ligands: Key Issues in Translation to Humans
Chapter 3 Pharmacodynamic and Pharmacokinetic Effects of Mk-0343
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Drugability of Extracellular Targets: Discovery of Small Molecule Drugs Targeting Allosteric, Functional, and Subunit-Selective Sites on Gpcrs and Ion Channels
GABAA Receptor Subtype- and Function-Selective Ligands: Key Issues in Translation to Humans
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Certificate of Analysis
Top View
Customs Tariff - Schedule
Selective Anxiolysis Produced by Ocinaplon, a GABAA Receptor Modulator A
Novel Pharmacological Targets in Drug Development for the Treatment of Anxiety and Anxiety-Related Disorders
Benzodiazepines: Their Use Either As Essential Medicines Or As Toxics Substances
Pharmaabkommen A1 E
Human Neurogenesis Assay: Ramelteon
Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
Neurogenesis Via Modulation of the Muscarinic Receptors
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
Automated in Silico Modelling and Docking of Ligands On
GABA and Sleep
Sleep Apnea and CMV Driver Safety
Etifoxine César Mattei, Antoine Taly, Zineb Soualah, Ophélie Saulais, Daniel Henrion, Nathalie C
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Improvements in the Pharmacological Profile of Diazepam by KRM-II-81, an Imidazodiazepine Positive Allosteric Modulator of 2/3-Containing GABAA Receptors
(12) Patent Application Publication (10) Pub. No.: US 2016/0279100 A1 ZHANG Et Al
Ethanol 40 L-Glutamic Acid 39 Zonisamide 30 Picrotoxin 22
(12) United States Patent (10) Patent No.: US 8,697,361 B2 Johnson (45) Date of Patent: Apr
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances